Data / Form D filings / PharmaCan Capital Corp.
PharmaCan Capital Corp.: Form D filings
PharmaCan Capital Corp., an investing company in Toronto, Ontario, Canada, filed 2 Form D notices with the SEC between 2015 and 2016. The latest, on May 27, 2016, reports $4.6 million sold of a $10.8 million offering to 21 investors.
Find out what PharmaCan Capital Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 76 STAFFORD STREET, SUITE 302, Toronto, Ontario, Canada, M6J 2
- Phone
- (416) 504-0004
- Industry
- Investing
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1656472
The full lists. Form D filings in Investing: 1,820 rows, $91, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2016 | New notice | $10,777,426 | $4,636,800 | $6,140,626 | 21 | May 13, 2016 | sec.gov |
| Oct 23, 2015 | New notice | $3,993,807 | $1,147,800 | $2,846,007 | 6 | Oct 8, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alan Friedman | Director | |
| Michael Gorenstein | Executive Officer, Director | |
| Glen Huber | Executive Officer | |
| Michael Howard Krestell | Director |
Every Form D from the week of May 23, 2016 · All recent Investing filings
Read from SEC EDGAR. Amount sold is what PharmaCan Capital Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.